18 and older, any sex, with Anorexia Nervosa or Atypical Anorexia Nervosa. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Participants Who Complete TrainingPrimary· Post-training (measured at the time of planned completion, which will be 10 weeks from the start of web-based training, or on the second day of live training)
Training completion will be the number of participants who complete the full course of training.
Group
Value
95% CI
Online Training
48
Live Training
22
Online Training
8
Live Training
7
Family-Based Treatment Knowledge Assessment (FBT-KA) Score at Post-TrainingPrimary· Baseline and post-training (measured immediately following completion of training)
The FBT Knowledge Assessment (FBT-KA) is an 28-item multiple-choice test that measures knowledge about FBT. Scores range from 0 to 28, with higher scores indicating more knowledge.
Group
Value
95% CI
Online Training
20.52
± 4.23
Live Training
18.30
± 2.96
Number of Participants Who Receive FBT Consultation at 12 MonthsSecondary· 12-month follow-up (measured at 12 months from the deadline for completion of training)
Providers will report on their receipt (yes/no) of FBT-specific consultation in the 12 months following completion of training.
Group
Value
95% CI
Online Training
28
Live Training
10
Online Training
21
Live Training
11
Online Training
7
Live Training
8
Sponsor's own description
This is a randomized controlled trial for mental health clinicians comparing two methods of training in family-based treatment (FBT) for restrictive eating disorders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young
· Phase 2
· recruiting
NCT07237607 — Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
· NA
· recruiting
NCT07188155 — Adapting Exposure for Adolescent AN
· NA
· recruiting
NCT07143981 — The Fecal Microbiome Transplant (FMT) Study for Anorexia Nervosa
· recruiting
NCT07311356 — Prognosis of Early-onset Anorexia Nervosa
· recruiting
Other University of California, San Francisco trials
Trials by the same sponsor.
NCT05284773 — Screening for Acute Malnutrition
· NA
· withdrawn
NCT04634851 — Video Home Visits for Dietary Counselling
· NA
· not yet recruiting
NCT06065670 — Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a M
· Phase 1, PHASE2
· not yet recruiting
NCT07534098 — Intervention for Hearing Health Among Native Americans
· NA
· not yet recruiting
NCT06960421 — Exercise-based Frailty Intervention in Lung Transplantation (XFIT)
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Francisco
Last refreshed: 7 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05389657.